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  Prophylactic eMcacy of long－term low－dose antimicrobial treatment in urinary tract infec． tion
（UTI） was studied． Female Patients with a history of at least two recurrent episodes of UTI in the
past year were entered into the study， and prophylactic regimens were not started until existing UTI
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had been’eradicated． Patients received prophylactic agent dai．ly at bedtime after voiding， and this
tteatment had been continued for 3 to 6 months．
    1． Nalidixic acid （NA） was administered 1．Og to adult’patients daily at bedtime， and children
．received each dose of 2500r 500皿g according to body weight． Fcmale pat量ents with unco血plicated
UTI were divided into two groups， the NA grouP （53 cases） and the placebo group （27 cases）， and
the incidence of reinfections in the NA group was significantly lower than in the placebo group both
at 3 and 6 ’高盾獅狽??（p〈O．05）． All patients with complicated UTI （16 men and 19 women） received
NA regimen， and the incidence of reinfections was 200／， at 3 months and 7．40／， at 6 months． Adverse
reactionsi of NA were noted in 7 of 88 patients （7．90／，） during the treatment． Anorexia was observed
in 5 cases， a rash in 1， and general itching in 1． No significant taboratory abnormalities were dbserved．
    2． Female adult patients were treated with one tablet of trimethoprirn－sulfamethoxazole （TMP
－SMX， 80 and 400 mg， respectively） daily at bedtime， while children received half the adult dose
taken according to the same schedule． Incidences of recurrence of UTI in 44 patients with uncom－
plicated UTI and 23 patients with complicated UTI were decreased to O．48 and O；52 per year during
the treatment eompared with 4．73 and 3．35． per year before entry into the study， respectively． After
completion of 6 months period of prophylactic therapy， patients who remained ．free from UTI were
divided into two groups by’?獅uelope method． ’Eleven cases ’wcre t’reated for a further 6 months and
12 cases followed by no medication． There was no significant differehce’ in the incidenCe o．f
recurrence between two groups． These findings suggest that the period pf prQphylaxis might be
suMcient for 6 months．
    Examination ofperiurethral swab showed that E． coli were present in 63．80／． of the subjects before
the treatment， while after 1 t’?3 months of treatment S． faecalis・were increased and E． co｝i were de－
creased． MICs of TMP－SMX against these organisms gencrally showcd a tcndcncy te increase during
the treatment．
    Urinar’y levels ofTMP－SMX in the morning urine with patients administered one tablet at bedtime
averaged 35．1ug／ml ’and 76．7 ug／ml， respectively． These values wgre about 2 times higher than
those found in the evening urine after administration of one tablet in the tnorning．
    Adverse reaction of TMPTSMX were observed in 7 of 67’ cases （．10，40／，）． As side effects， two
cases of thrombocytopenia and one case of elevatioR of serum alkaline－phosphatase ． were observed
but all of side effects were transient．
































































 非複雑性UTI 80例のうちNA群は53例， placebo
群は27例で，このうち3ヵ月までの期間内に再発をき
たした症例はNA群2例（3． 8％）， placebo群7例
Table 1．Number of patients remaining uninfected or becoming reinfected
after various periods of prophylactic treatment with nalidixic acid
Uncomp質cated UTI Complicated UTI
Period Qf
狽窒?♂ﾁent Nalidixic acid      PlaceboNah出xic acid
（m。nths）
Unテnfec Reinfec Uninfec Re｛nfec





51   2    20   7
S0   1    9   ア
＜0．05
モO．05
28   7
Q5   2
Table 2．Infecting organisms in patients reinfected during prophylactic
treatment with naiidixic acid
maU n  l tdUTI ．1；．Qtg］mlicated UTIOrganism Nalidixic acidPlacebo Nalidixic acid
Before Reinfec Before Reinfec Before Reinfec



















































































Table 3． Side effects of nalidixic acid
     treatment in 88 patients





































Table 4． Age distribution of patients received pro－
     phylactic treatment with trimethoprim－













































Tota113 31 23 6ア





Conditions of patients with UTI at the time of starting prophylactic
treatrnent with trimethoprim－sulfamethoxazole
2Jr s
Conditions No． of pts．
1， pati．’ents w・i’th sterile urine at the time
 of starti｛ng prophylaxis
2． pati’ents with infected uri’ne received a
 short course of another antibi．otic before starting prophylaxis





































   （mean）
4．56 5．00 4．71




patients 一一 months200．5 115．0 313．5
Patients with
























Incidence of recurrence （O／．） during prophylactic
treatment with trimethoprim－sulfamethoxazole
Uncomplicated
   UTI Complicated       Total  UTI
No．of patients44 23 67
Patients w－ith
recurrence 8 5 13
Incidence of
recurrence（％）18．2 21．7 19．4
P value Not significant



























No． of infections          4．73Patients－years 3．35 4．13
Table I O． Comparison of incidence of infectiQn per year between before
     and after treatment with trimethoprim－sulfamethoxazole
             No．of infections／Patients－year
Before treatment After treatrneht P value
Uncompl icated U丁1   4．73士2．41O．48±1．69 P・O．05






























Table 11． Periurethral organisms and MICs （No． of cases：36）
MIC Cvg／ml）
Organisms
sl．56 3．13 6．25 12．5 25 50 IOOE
Total （ ％ ）
巳・P
E．coli 2 5 10 6 23 （63．8％）
の」邸









⊆口 →」 ’rota1 8 9 10 7 2 3 2 41
E．coli 3 4 4 1 12 （33．3諾）
～一ρ
Φ ＝
ﾋ Φ Klebsiella τ 1 1 3 （8．3老｝甲 E…邸十」
@ ◎ S．faecalis 5 8 13 （36．1箔）ω Φ
H＝ 5＿
¥」十ρ Staphylococcus1 1 4 1 ア （19．4器）
＝
o σ）
ｸ ⊆ 三nterobacter 1 1 （2．8傷）
・Pρり →」@ LPseudomonas 1 1 （2．8％）
， ◎
ρ
ド胃 の 了ota… 1 4 9 6 8 9 37

















Patients：the mDrning urine Volunteers：the morning urineadministered one tablet administered one tablet at
（SMX400mg，丁MP 80mg）at bedtime． bedtime．
Fig． 1．
Volunteers：the urine at 10－12hou s after administration of
one tablet．
Comparison of urinary concentration of SMX and TMP between























Comparison of timing of infections between trimethoprim－




SMX－TMP＊ groupNo medication group
     Patients withNo．of pts．     infection
    Patfients withNo．of pts．     infection
















Tota1 11 3 12 3
SMX－TMP＊：・ trimethoprim－sul famethoxazole
Table 13．Comparison of reinfections between trimethoprim－sulfamethoxazole group
and no medication group after prophylaxis of six－months course







P value Not significant
Table 14． Side effects of tri皿ethoprim－
     sulfamethoxazole treatment ・in
     67 patients
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